Nexgel Net Income from 2010 to 2026
| NXGL Stock | USD 1.21 0.04 3.20% |
Net Loss | First Reported 2017-12-31 | Previous Quarter -665 K | Current Value -653 K | Quarterly Volatility 357.5 K |
Check Nexgel financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Nexgel's main balance sheet or income statement drivers, such as Depreciation And Amortization of 298.3 K, Total Revenue of 10.5 M or Gross Profit of 3.3 M, as well as many indicators such as Price To Sales Ratio of 3.65, Dividend Yield of 0.0 or PTB Ratio of 5.51. Nexgel financial statements analysis is a perfect complement when working with Nexgel Valuation or Volatility modules.
Nexgel | Net Income | Build AI portfolio with Nexgel Stock |
Historical Net Income data for Nexgel serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether Nexgel Inc represents a compelling investment opportunity.
Latest Nexgel's Net Income Growth Pattern
Below is the plot of the Net Income of Nexgel Inc over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Nexgel Inc financial statement analysis. It represents the amount of money remaining after all of Nexgel Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Nexgel's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Nexgel's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (3.28 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Nexgel Net Income Regression Statistics
| Arithmetic Mean | (2,412,203) | |
| Coefficient Of Variation | (42.25) | |
| Mean Deviation | 832,262 | |
| Median | (1,888,000) | |
| Standard Deviation | 1,019,270 | |
| Sample Variance | 1T | |
| Range | 3.8M | |
| R-Value | (0.68) | |
| Mean Square Error | 592.1B | |
| R-Squared | 0.47 | |
| Significance | 0 | |
| Slope | (137,739) | |
| Total Sum of Squares | 16.6T |
Nexgel Net Income History
Other Fundumenentals of Nexgel Inc
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Nexgel Net Income component correlations
About Nexgel Financial Statements
Nexgel investors utilize fundamental indicators, such as Net Income, to predict how Nexgel Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Loss | -3 M | -3.1 M | |
| Net Loss | -4.3 M | -4.5 M | |
| Net Loss | -3.1 M | -3.3 M | |
| Net Loss | (0.58) | (0.61) | |
| Net Income Per E B T | 1.09 | 1.07 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of Nexgel Correlation against competitors. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nexgel. Anticipated expansion of Nexgel directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Nexgel assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.40) | Revenue Per Share | Quarterly Revenue Growth (0) | Return On Assets | Return On Equity |
Investors evaluate Nexgel Inc using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Nexgel's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Nexgel's market price to deviate significantly from intrinsic value.
It's important to distinguish between Nexgel's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nexgel should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Nexgel's market price signifies the transaction level at which participants voluntarily complete trades.